Future FinTech Group Inc. (FTFT) At $4.23 Forms Bottom; Selecta Biosciences (SELB) SI Decreased By 7.35%

Future FinTech Group Inc. (FTFT) formed multiple bottom with $3.98 target or 6.00% below today’s $4.23 share price. Future FinTech Group Inc. (FTFT) has $21.88M valuation. The stock increased 1.93% or $0.08 during the last trading session, reaching $4.23. About 258,320 shares traded. Future FinTech Group Inc. (NASDAQ:FTFT) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Selecta Biosciences Incorporated (NASDAQ:SELB) had a decrease of 7.35% in short interest. SELB’s SI was 1.60M shares in January as released by FINRA. Its down 7.35% from 1.72 million shares previously. With 264,500 avg volume, 6 days are for Selecta Biosciences Incorporated (NASDAQ:SELB)’s short sellers to cover SELB’s short positions. The stock increased 1.97% or $0.17 during the last trading session, reaching $8.79. About 141,101 shares traded. Selecta Biosciences, Inc. (NASDAQ:SELB) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company has market cap of $196.34 million. The Company’s lead product candidate is SEL-212, which is in phase I/II clinical trials for the treatment of refractory and chronic tophaceous gout. It currently has negative earnings.